Rare diseases
Investigational molecules
Locations
Back to France663 clinical trials in Grenoble, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial
FranceDocetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment
FranceNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
FrancePumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
FranceStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
FranceQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
FranceLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
FranceFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
FranceEvaluating the use of capecitabine, oxaliplatin, fluorouracil, folinic acid, and irinotecan to personalize chemotherapy for patients with stage III colorectal cancer
FranceA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
FranceA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
FranceOne-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on head and neck cancers, multiple myeloma, and various types of leukemia. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.
Innovative approaches combining immunotherapy with standard treatments are showing promise in treating various forms of cancer.
Clinical investigations examining kidney transplant outcomes and rejection prevention. Research focuses on new therapeutic approaches for managing transplant-related complications.
Studies aim to improve transplant success rates and reduce rejection incidents through innovative medication protocols.
Research into narcolepsy and multiple sclerosis treatments, evaluating new therapeutic approaches for better symptom management and disease control.
Cutting-edge treatments being developed to address both rare and common neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
